End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.65 SEK | +18.60% | +34.21% | +53.00% |
02/05 | ODI Pharma AB Provides Sales Guidance for the Third Quarter of the Year 2024 | CI |
22/02 | ODI Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 | CI |
Business Summary
Number of employees: 1
Sales per Business
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceuticals Cannabis and Cosmetic Products
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -55.44% |
Sales per region
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Sweden
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -55.44% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Derek Simmross
FOU | Founder | 56 | 01/18/01 |
Markus Fritzsche
CTO | Chief Tech/Sci/R&D Officer | - | - |
Karina Kilinski
BRD | Director/Board Member | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Derek Simmross
FOU | Founder | 56 | 01/18/01 |
Founder | 44 | 01/18/01 | |
Karina Kilinski
BRD | Director/Board Member | - | - |
Gösta Lidén
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 15,220,000 | 15,067,800 ( 99.00 %) | 0 | 99.00 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+53.00% | 10.78M | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |
- Stock Market
- Equities
- ODI Stock
- Company ODI Pharma AB